2011 Events
1. “Sex, Steroids and the Skeleton”
Thursday, February 17, 2011
Location: Georgetown University
Sundeep Khoasla, MD
Educational objectives:
─ Understand the role of sex steroids in regulating bone metabolism in women and men
─ Define relative changes in trabecular versus cortical bone over the life of humans
─ Define the clinical implications of our new understanding of estrogen regulation of bone metabolism
2. “Osteoimmunology”
Thursday, March 17, 2011
Location: La Ferme Restaurant Bethesda
Joseph Lorenzo, MD
Educational objectives:
─ Understand crosstalk between the immune system and bone remodeling
─ Understand how to prevent inflammatory bone destruction in oral and axial/appendicular bone
─ Define determinants of serum sclerostin levels and the implications for the prevention of postmenopausal osteoporosis
3. “Osteoblasts and Insulin Action”
Tuesday, May 17th, 2011
Location: Tragara Restaurant Bethesda
Thomas L. Clemens, PhD
Ed Educational objectives:
─ Understand growth hormone and insulin actions in bone
─ Understand the regulation of osteoblast activity and bone formation
─ Understand how fracture repair is influenced by growth factors
4. “Comparing the Effects of Alendronate and Denosumab on Bone Microarchitecture”
Tueasday, June 7th 2011
Location: Ritz-Carlton, VA
Ego Seeman, MD
Educational objectives:
─ Understand microarchitectural degeneration of cortical and trabecular bone in postmenopausal osteoporosis
─ Define differences in the mechanisms of actions for Alendronate and Denosumab
─ Understand determinants of bone fragility
5. “Serotonin and Osteoporosis”
Thursday, September 8, 2011
Location: Nora, DC
Gerard Karsenty, MD, PhD
Educational objectives:
─ Understand how gut-derived serotonin inhibits bone formation
─ Understand how the leptin-serotonin pathway influences body weight and bone mass
─ Review emerging anabolic treatments for osteoporosis
6. “Osteoporosis Treatment and Renal Insufficiency”
Thursday, October 20th 2011
Location: Morton’s Steakhouse VA
Paul Miller, MD
Educational objectives:
─ Distinguish between therapeutic options available for the prevention and treatment of osteoporosis based on mechanism of action, safety, efficacy, and fracture risk assessment
─ Understand different stages of renal insufficiency influence bone remodeling
─ Understand the differences between the effects of Denosumab, bisphosphonates, and intermittent PTH in postmenopausal women with high risk for renal disease.
7. Directors dinner "Current Topics in Osteoporosis"
Tuesday, December 13th
Location: 1789 Restaurant Washington DC